(Press-News.org) Transformative changes in markets, policy and science, rather than just incremental changes in farming practices and technology, will be critical if the United States is to achieve long-term sustainability in agriculture, according to a nationwide team of agriculturists that includes a University of California, Davis, animal scientist.
The team's recommendations, first published as a 2010 report by the U.S. National Research Council, appear as a Policy Forum piece in the May 6 issue of the journal Science. Lead author on the paper is John Reganold, Regents Professor of soil science and agroecology at Washington State University, Pullman.
"For decades, the agricultural industry, research community and government, have looked to incremental improvements in agricultural procedures and technologies for achieving advances in productivity," said Deanne Meyer, a Cooperative Extension livestock waste management specialist in the UC Davis Department of Animal Science and a member of the research team.
She noted that such incremental improvements have included adoption of two-year crop rotations, precision agriculture technologies, classically bred and genetically engineered crops, and reduced- or no-tillage management systems.
"While all of these have resulted in important improvements, it's become apparent that as modern agriculture also grapples with important issues such as global climate change, biodiversity, resource conservation and public health problems, a more transformative approach is needed," she said.
Such an approach would balance production goals with long-term sustainability concerns involving the environmental, social and economic impacts of agriculture. It would focus on a "whole-system redesign" that would address policy and market issues, as well as technological issues, the researchers recommend in their report.
The approach would incorporate innovative agricultural systems such as organic farming, grass-fed and other alternative livestock production systems, mixed crop and livestock systems, and perennial grains. And it would require significant changes in market structures, policy incentives and public funding for agricultural science, according to the report.
The research team suggests that with a new version of the U.S. Farm Bill due in 2012, the time is now ripe to begin reforming U.S. agriculture.
INFORMATION:
The team's 598-page 2010 National Research Council report, "Toward Sustainable Agricultural Systems in the 21st Century," is available online at: http://books.nap.edu/openbook.php?record_id=12832&page=R1
Media contacts:
-- Deanne Meyer, Animal Science, (530) 752-9391, dmeyer@ucdavis.edu
-- Pat Bailey, News Service, (530) 752-9843, pjbailey@ucdavis.edu
END
Tests of a new antibody-based "biosensor" developed by researchers at the Virginia Institute of Marine Science show that it can detect marine pollutants like oil much faster and more cheaply than current technologies. The device is small and sturdy enough to be used from a boat.
Testing of the biosensor in the Elizabeth River and Yorktown Creek, which both drain into lower Chesapeake Bay, shows that the instrument can process samples in less than 10 minutes, detect pollutants at levels as low as just a few parts per billion, and do so at a cost of just pennies per sample. ...
The Hand and Wrist Institute, the leading hand specialist experts in the State of California now offers a "Where Does It Hurt" tool on their website, www.handandwristinstitute.com.
The Hand and Wrist Institute is a medical center that focuses primarily on the surgery of hands and wrists. This institute is backed by Dr. John T. Knight, one of the top medical experts in the field of hand and wrist surgery. Dr. John T. Knight is a board certified Orthopedic Surgeon who oversees the operations of the Hand and Wrist Institute at DISC to ensure that all of their ...
Scientists from the Walter and Eliza Hall Institute and the University of Melbourne have used innovative new technologies to identify the gene responsible for a rare but fatal hereditary brain disorder. The discovery will make it possible to diagnose the disease through a blood test rather than a brain biopsy.
Dr Melanie Bahlo, Ms Katherine Smith and Ms Catherine Bromhead from the Walter and Eliza Hall Institute's Bioinformatics division, in collaboration with neurologist and epilepsy specialist Professor Sam Berkovic and Dr Todor Arsov from the University of Melbourne, ...
The Psychological Care and Healing Treatment Center, the leading destination for people who want to have their psychological disorders fixed, now offers Panic Disorder treatment Clinic.
A Panic Disorder is considered as such when a person experiences several panic attacks within a short period of time. First of all, people must know that panic attacks are not very common. In fact, some people live their lives and experience only as little as two or three panic attacks through out their lives. This is why it is very uncommon to experience or suffer from several panic ...
French researchers have reported the strongest proof yet that evidence of 'circulating tumor cells' found in samples of a patient's blood is strongly linked to poor outcomes such as a short time to disease progression.
At the IMPAKT Breast Cancer Conference in Brussels, Dr François-Clement Bidard and colleagues from Institut Curie in Paris say their new findings set the scene for interventional trials designed to see if improved outcomes can be achieved by modifying treatment based on circulating tumor cell counts.
"We needed to do this study to confirm data provided ...
The most comprehensive analysis yet of the epigenetic modifications present in breast cancer has revealed potentially important new ways to detect and treat the disease, Belgian researchers have reported.
Epigenetics is a term used to describe modifications to the DNA molecule that affect way its code is translated into proteins. These changes include methylation, a form of chemical modification.
Although researchers knew epigenetics was important in cancer, information about its exact contribution to breast carcinogenesis was scant, Dr Sarah Dedeurwaerder, from Université ...
German researchers have identified an unexpected molecular marker that predicts how sensitive hard-to-treat triple-negative breast cancers are to chemotherapy.
Triple-negative breast cancers --which do not express the genes for estrogen receptor, or progesterone receptor and do not have Her2/neu overexpression or amplification-- are more aggressive than other forms of the disease and cannot be treated with endocrine or Her2 targeted therapies.
At the IMPAKT Breast Cancer Conference in Brussels, PhD student Carolin Huelsewig and Dr Cornelia Liedtke from Uniklinikum Muenster ...
Two multi-gene tests designed to predict the risk of disease progression and response to chemotherapy in breast cancer produce broadly similar results for high- and low-risk patients, but do not always agree in their predictions for those at intermediate risk, a new analysis shows.
In recent years, several genomic tests have been developed to provide prognostic information for breast cancer. Dr Catherine Kelly from Mater Misericordiae University Hospital, Dublin, Ireland, and colleagues in the USA examined the agreement in prediction results between two multi-gene assays ...
Measuring the transfer of tiny amounts of energy from one protein to another on breast cancer cells has given scientists a detailed view of molecular interactions that could help predict how breast cancer patients will respond to particular therapies.
At the IMPAKT Breast Cancer Conference in Brussels, Dr Gargi Patel from the Richard Dimbleby Department, King's College London, described cutting-edge research in which she and colleagues captured detailed information about protein interactions on cancer cells, and correlated that with established genetic markers for cancer ...
The anti-inflammatory drug celecoxib may be a useful additional treatment for people with breast cancer, Dutch researchers report at the IMPAKT Breast Cancer Conference in Brussels.
The results of a randomized trial in 45 patients with primary invasive breast cancer showed that the drug --which is currently used to treat arthritis and other painful conditions-- clearly induced an anti-tumor response at the molecular level.
"This is exciting because it means that a medication already used to treat other diseases may be efficient in the adjuvant treatment of breast cancer ...
